24S Group. Randomized trial of cholesterol lowering in4444 patients with coronary heart disease. Lancet. 1994,344(19): 1383～ 1389
3Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996,335:1001 ～ 1009
4The long- term intervention with pravastatin ischemic disease(LIPID)study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998,339:1349～ 1357
5Clarke RJ, Mayo G, Price P, et al. Suppression of thromboxane A2 but not of prostacyclin by controlled-release aspirin. N Engl J Med, 1991, 325:1137.
6Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med, 1992, 327(3):175.
